Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?
- 1 April 2018
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 39 (4) , 718-725
Abstract
To analyze the role of sensitive cardiac troponin I (scTnI) and high-sensitive troponin T (hscTnT) in the determination of myocardial injury caused by volume and pressure load due to pulmonary hypertension (PH) and to investigate if these markers may be useful in the management of PH in childhood. Twenty-eight patients with congenital heart disease (CHD) with left to right shunt and PH, 29 patients with CHD with left to right shunt but without PH, and 18 healthy children, in total 75 individuals, were included in the study. All cases were aged between 4 and 36 months. Echocardiographic evaluation was performed in all cases, and invasive hemodynamic investigation was performed in 33 cases. Blood samples were obtained from all cases, for the measurement of brain natriuretic peptide (BNP), pro-brain natriuretic peptide (pro-BNP), sensitive cardiac troponin I (scTnI), and high-sensitive troponin T (hscTnT) levels. The mean BNP, pro-BNP, scTnI, and hsTnT levels were statistically significantly higher in patients with PH than in the patients without PH (p < 0.001). A statistically significant positive correlation was determined between pulmonary artery systolic pressure and scTnI and hscTnT levels (r = 0.34 p = 0.01, r = 0.46 p < 0.001, respectively) levels. Pulmonary hypertension determined in congenital heart diseases triggers myocardial damage independently of increased volume or pressure load and resistance, occurring by disrupting the perfusion via increasing ventricular wall tension and the myocardial oxygen requirement. Serum scTnI and hscTnT levels may be helpful markers to determine the damage associated with PH in childhood.Keywords
This publication has 44 references indexed in Scilit:
- Echocardiography in Pulmonary Arterial Hypertension: from Diagnosis to PrognosisJournal of the American Society of Echocardiography, 2013
- B-type Natriuretic Peptide and Amino-terminal Pro-B-type Natriuretic Peptide in Pediatric Patients with Pulmonary Arterial HypertensionCongenital Heart Disease, 2012
- Role of CA‐125 in Identification of Right Ventricular Failure in Chronic Obstructive Pulmonary DiseaseClinical Cardiology, 2011
- Volume Overload and Pressure Overload due to Left-to-Right Shunt-Induced Myocardial Injury - Evaluation Using a Highly Sensitive Cardiac Troponin-I Assay in Children With Congenital Heart Disease -Circulation Journal, 2011
- High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertensionClinical Science, 2010
- Serum Cardiac Troponin I is Related to Increased Left Ventricular Wall Thickness, Left Ventricular Dysfunction, and Male Gender in Hypertrophic CardiomyopathyClinical Cardiology, 2010
- A New Season for Cardiac Troponin Assays: It’s Time to Keep a ScorecardClinical Chemistry, 2009
- Brain Natriuretic Peptide Levels in Managing Pediatric Patients With Pulmonary Arterial HypertensionChest, 2009
- Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s SyndromeDrugs, 2008
- Substantial intraindividual variability of BNP concentrations in patients with hypertensionJournal of Human Hypertension, 2006